Helena Mistry obtained her BS.c in Biomedical Sciences, from the University of Waterloo, and her Ph.D., in Pharmacology and Toxicology from the University of Toronto, in Canada. She then went on to pursue a postdoctoral fellowship at the Dana Farber Cancer Center, at the Harvard Medical School, in Boston, MA. Helena is good at combining her extensive scientific background with strong business acumen. In her current role as Director of Business Development at Imeka, she initiates and leads the collaboration processes with multiple large pharma companies. In the past, she has worked in Business Development managerial roles at Eurofins Lancaster Laboratories and Cubresa.